Iain was appointed to the Board in November 2007 and is currently serving as Chairman.
Iain is an experienced private consultant, investor and nonexecutive director (both listed and unlisted public companies). He has considerable practical and operational experience gained from a successful financial career spanning 35 years in a range of industries including auditing, resources, manufacturing and latterly healthcare in Australia, Britain and the USA. He started his career at Arthur Andersen & Co in London. Before establishing himself as a consultant/advisor and joining a number of boards as a non‑executive director, Iain held a range of senior financial and general management positions in Woodside Petroleum Ltd, Santos Ltd, Pilkington plc, F.H. Faulding & Co Ltd and Clinuvel Pharmaceuticals Limited.
Iain is a Non‑Executive Director of ASX listed companies Medical Developments International Ltd (ASX:MVP), Vision Group Holdings Ltd (ASX:VGH) and Chairman of Avexa Limited (ASX:AVX).
Joe has more than 20 years in the pharmaceutical industry, focused on commercialisation, marketing and sales including partnership, government and licensing negotiations. Most notably, he is the former General Manager of Gilead Sciences Australia, New Zealand and Asia, one of the largest biopharmaceutical companies in the world. Prior to Gilead, he was Marketing Director for Bayer Australia, and also held management positions at Pharmacia & Upjohn and Merck Sharp & Dohme. Joe is also the former Chairman of Avexa Limited (ASX: AVX), an Australian biotechnology company, where he had been a director since April 2009.
Joe has been involved with bluechiip since mid‑2008 and has been a key contributor to the organisation in strategy and business development, including key partner discussions and negotiations on behalf of bluechiip. This continues to ensure bluechiip operations are kept in line with the company’s vision of providing solutions to the healthcare sector as an initial market strategy. Joe has also been instrumental in assisting bluechiip’s product development and customer interactions through proof‑of‑concept studies and pilot trials.
Joe is a Director and founder of eXec Factor Pty Ltd, an executive leadership consulting company. He is currently on the Board of the BioMelbourne Network.
He holds a Bachelor of Science degree in Pharmacology and Biochemistry from the University of Melbourne.
Ron Finkel LLB, Bcom (Melb)
Ron has been actively involved in the venture capital industry since 1986 including roles at Pratt Venture Management and as Director of Investments at the Advent Management Group where he led investments in a number of portfolio companies across a wide range of innovative technologies.
In 1997, together with his colleague Ergad Gold, he established the Momentum Investment Group and were successful tenderers for one of the Australian Governments inaugural licenses under the Innovation Investment Fund program.
Ron is currently Chairman of Panviva Pty Ltd and a Director of Momentum Investment Group, Momentum Ventures Ltd, Benthic Geotech Pty Ltd, Petrecycle Ltd and AlphaPet Limited.
Lee was previously a partner in a premier mid‑tier law firm in their corporate group. He remains a qualified solicitor practising principally in corporate and commercial law advising on corporate and securities regulation, capital raisings, formulation and implementation of mergers and acquisitions, corporate governance and secretarial matters.